Intravenous Ondansetron Safety During Pregnancy

Safety Profile of Ondansetron in Pregnancy

The American College of Oncology notes that ondansetron is considered generally safe during pregnancy, though there are some concerns about first-trimester use 1
The use of ondansetron in early pregnancy has been associated with a marginal relative increase in cleft palate and cardiovascular malformations, particularly ventricular septal defects 1

The American Gastroenterological Association recommends that ondansetron should be considered a second-line treatment after first trying other antiemetics with more established safety profiles during pregnancy, with a standard dosing of 8 mg IV every 4-6 hours during episodes of nausea and vomiting 2
The American College of Oncology states that when ondansetron is necessary, it remains widely used in clinical practice for severe nausea and vomiting of pregnancy 1

The European Society for Clinical Gastroenterology notes that metoclopramide (5-10 mg orally every 6-8 hours) is considered safe in pregnancy with no significant increased risk of major congenital defects based on meta-analysis of studies including over 33,000 first-trimester exposures 1
The American College of Oncology recommends that steroids (methylprednisolone or prednisolone) are safe after 10 weeks gestation but should be avoided before 10 weeks due to potential increased risk of oral clefts 1

The American Association for the Study of Liver Diseases notes that the risk-benefit ratio should be carefully considered, especially in cases of hyperemesis gravidarum where dehydration and malnutrition pose significant risks to both mother and fetus 3
The American College of Oncology states that for pregnant patients receiving chemotherapy, ondansetron is considered safe and effective for preventing chemotherapy-induced nausea and vomiting 1
The American Gastroenterological Association recommends that when using ondansetron, baseline ECG monitoring is advised due to potential QTc prolongation 2

The American Gastroenterological Association recommends ondansetron as second-line therapy, noting it has not been associated with increased risk of stillbirth, spontaneous abortion, or major birth defects overall, in pregnant women in their second trimester 4
Ondansetron can be used in the second trimester of pregnancy for severe nausea and vomiting, as the theoretical concerns about congenital malformations are specific to first-trimester exposure during organogenesis, and the drug is considered safe and effective after 10 weeks gestation, according to the American College of Gastroenterology 4

Ondansetron should be used as a second-line agent after trying first-line antiemetics, with standard dosing of 8 mg IV every 4-6 hours during episodes of nausea and vomiting, in pregnant women in their second trimester, as recommended by the American Gastroenterological Association 4
For severe nausea and vomiting requiring hospitalization that has not responded adequately to first-line agents, ondansetron can be used in the second trimester, as the benefits outweigh the risks, according to the American College of Obstetricians and Gynecologists 4

Monitor for adequate hydration and electrolyte balance, particularly potassium, as ondansetron-induced QTc prolongation risk increases with electrolyte abnormalities, in pregnant women in their second trimester, as recommended by the American Heart Association 4
Ensure thiamine supplementation is provided to prevent Wernicke encephalopathy in cases of prolonged vomiting, in pregnant women in their second trimester, as recommended by the American College of Gastroenterology 4